AU3994100A - Use of low affinity nmda antagonists for the treatment of headache - Google Patents

Use of low affinity nmda antagonists for the treatment of headache

Info

Publication number
AU3994100A
AU3994100A AU39941/00A AU3994100A AU3994100A AU 3994100 A AU3994100 A AU 3994100A AU 39941/00 A AU39941/00 A AU 39941/00A AU 3994100 A AU3994100 A AU 3994100A AU 3994100 A AU3994100 A AU 3994100A
Authority
AU
Australia
Prior art keywords
headache
treatment
low affinity
nmda antagonists
affinity nmda
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39941/00A
Other languages
English (en)
Inventor
Hans Basun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU3994100A publication Critical patent/AU3994100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU39941/00A 1999-04-06 2000-04-04 Use of low affinity nmda antagonists for the treatment of headache Abandoned AU3994100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9901237 1999-04-06
SE9901237A SE9901237D0 (sv) 1999-04-06 1999-04-06 Novel use
PCT/SE2000/000643 WO2000059496A1 (en) 1999-04-06 2000-04-04 Use of low affinity nmda antagonists for the treatment of headache

Publications (1)

Publication Number Publication Date
AU3994100A true AU3994100A (en) 2000-10-23

Family

ID=20415133

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39941/00A Abandoned AU3994100A (en) 1999-04-06 2000-04-04 Use of low affinity nmda antagonists for the treatment of headache

Country Status (4)

Country Link
AR (1) AR023389A1 (xx)
AU (1) AU3994100A (xx)
SE (1) SE9901237D0 (xx)
WO (1) WO2000059496A1 (xx)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993020052A1 (en) * 1992-04-03 1993-10-14 Fisons Corporation Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders
SG52662A1 (en) * 1988-08-12 1998-09-28 Astra Ab Arylkalkyl-amines and -amides having anticonvulsant and neuroprotective properties
DE69201141T2 (de) * 1991-02-28 1995-05-11 Merrell Dow Pharma NMDA-Antagonisten.
CA2115792C (en) * 1993-03-05 2005-11-01 David J. Mayer Method for the treatment of pain
WO1995006468A1 (en) * 1993-09-01 1995-03-09 Smithkline Beecham Corporation Method for treating migraine headaches
IS4233A (is) * 1993-12-22 1995-06-23 Astra Aktiebolag Misleit hringtengd efnasambönd
DE19510189A1 (de) * 1995-03-21 1996-09-26 Hartmut Dr Goebel Verwendung von Amantadin
AUPN605795A0 (en) * 1995-10-19 1995-11-09 F.H. Faulding & Co. Limited Analgesic pharmaceutical composition
EP1011656A2 (en) * 1996-11-05 2000-06-28 Head Explorer ApS A method for treating tension-type headache

Also Published As

Publication number Publication date
WO2000059496A1 (en) 2000-10-12
SE9901237D0 (sv) 1999-04-06
AR023389A1 (es) 2002-09-04

Similar Documents

Publication Publication Date Title
AU2002224927A1 (en) Use of substituted imidazoazines, novel imidazoazines, methods for the production thereof, and agents containing these compounds
AU2001241068A1 (en) Indole derivatives, process for preparation of the same and use thereof
AU2001240115A1 (en) Method for the preparation of tetrahydrobenzothiepines
IL158693A0 (en) Azole compounds, process for preparation of the same and use thereof
IL145334A0 (en) The use of certain affinity nmda antagonists as antidepressants
AU7902400A (en) Method for the preparation of 5-carboxyphthalide
AU2035401A (en) Lubricant combination and process for the preparation thereof
AU2001267831A1 (en) DDS compound and process for the preparation thereof
AU4364400A (en) Azaindole derivatives for the treatment of depression
AU2001293891A1 (en) New combination for the treatment of asthma
AU2376001A (en) Method for the manufacture of olefins
AU2002330042A1 (en) Process for the preparation of 1,5-diarylpyrazoles
AU2001252671A1 (en) Pyridobenzodiazine derivatives and processes for the preparation thereof
AU2829700A (en) Processes for the preparation of alpha-aminoketones
AU2002329441A1 (en) Process for the preparation of 3 - isochromanone
AU1130901A (en) Method for the preparation of 5-carboxyphthalide
AU3994100A (en) Use of low affinity nmda antagonists for the treatment of headache
AU2002358085A1 (en) Process for the preparation of 4-methyl-7-aminoquinolones
AU6230499A (en) Method for preparing 2-chloropropionaldehyde and use of the same
AU2001227095A1 (en) Processes for the preparation of carbapenem derivatives
AU2002324291A1 (en) Process for the preparation of beta-ionylideneacetaldehyde
AU5462901A (en) Process for the preparation of (pyridinylidene)-phthalides
AU2001268903A1 (en) Hexaglucal compound and the use and the methods of preparing them
AU2000279379A1 (en) An improved process for the preparation of 10h-phenoxazine
AU4475300A (en) Tetrahydroisoquinolinyl-indole derivatives for the treatment of depression

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase